XML 58 R52.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Licensing Revenue Agreement - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Deferred Revenue Arrangement [Line Items]            
License revenue recognized $ 0 $ 161,000 $ 0 $ 442,000    
Deferred revenue 0 0 0 0 $ 0 $ 442,000
Merck Neuromuscular License Agreement            
Deferred Revenue Arrangement [Line Items]            
License revenue recognized $ 0 $ 5,000,000 $ 0 5,000,000    
Milestone payments       $ 5,000,000